Current Edition

biosimilars

Biotech execs who pinched Genentech trade secrets headed to prison

Top execs at Taiwanese biosimilars outfit JHL Biotech are headed to prison after pleading guilty last August to stealing trade secrets from Roche’s Genentech. Racho …

Continue Reading →
biotech

Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late?

It’s finally here: After a series of delays in the lead-up to Novavax’s COVID-19 vaccine filing with the FDA, the biotech has completed its emergency …

Continue Reading →
biotech

Totus tots up $40M in series A funding to go after competitive cancer space

Totus Medicines is making a play for the PI3Kα inhibitor market. Exiting stealth with a $40 million series A round, the Massachusetts-based biotech plans to …

Continue Reading →
biotech

Intricacies and Future Considerations for the Cell and Gene Therapy Cold Chain

The rapidly growing field of cell and gene therapy is both exciting and confusing to many, including those who work in the medical community and …

Continue Reading →
biotech

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

The New Global Rare Disease Center of Emmes Expects Accelerating Growth from US and European Biotechs 03rd November, 2021, Rockville, Maryland (USA): Emmes – a full service, global …

Continue Reading →
BioNTech

What would Medicare price negotiations bring to the US? Look to Europe, Lilly CEO Ricks says

When posed with the decades-old question of how drug price reform would affect their operations in the U.S., pharma execs have a ready-made response: Reducing …

Continue Reading →